Cargando…

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas

Increasing evidences have implicated somatic gain-of-function mutations at the telomerase reverse transcriptase (TERT) promoter as one of the major mechanisms that promote transcriptional activation of TERT and subsequently maintain telomere length in human cancers including glioma. To investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Ke, Li, Gang, Qu, Yiping, Wang, Maode, Cui, Bo, Ji, Meiju, Shi, Bingyin, Hou, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890999/ https://www.ncbi.nlm.nih.gov/pubmed/26556853 http://dx.doi.org/10.18632/oncotarget.6007

Ejemplares similares

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
por: Heidenreich, Barbara, et al.
Publicado: (2015)

Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
por: Diaz de Leon, Alberto, et al.
Publicado: (2010)

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival
por: Wei, Jing, et al.
Publicado: (2019)

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2016)

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017)

Telomere Length, TERT, and miRNA Expression
por: Slattery, Martha L., et al.
Publicado: (2016)

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
por: Walsh, Kyle M., et al.
Publicado: (2014)

Telomere length and hTERT in mania and subsequent remission
por: Çinar, Rugül Köse
Publicado: (2017)

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAF(V600E)-driven human cancers
por: Wu, Yongxing, et al.
Publicado: (2021)

TERT Mutation Is Accompanied by Neutrophil Infiltration and Contributes to Poor Survival in Isocitrate Dehydrogenase Wild-Type Glioma
por: Gao, Mengqi, et al.
Publicado: (2021)

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
por: Dratwa, Marta, et al.
Publicado: (2021)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

c-Myc is Required for BRAF(V600E)-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
por: Qu, Yiping, et al.
Publicado: (2017)

Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells
por: Ravindranathan, Ajay, et al.
Publicado: (2018)

Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients
por: Rampazzo, Enrica, et al.
Publicado: (2020)

Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas
por: Ventura Ferreira, Monica S., et al.
Publicado: (2018)

Genetic Variants of the TERT Gene and Telomere Length in Obstructive Sleep Apnea
por: Macek, Piotr, et al.
Publicado: (2022)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

Telomere length connects melanoma and glioma predispositions
por: Endicott, Alyson A., et al.
Publicado: (2016)

Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia
por: Wysoczanska, Barbara, et al.
Publicado: (2019)

Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
por: Dratwa, Marta, et al.
Publicado: (2023)

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients
por: Chen, Lihong, et al.
Publicado: (2016)

Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns
por: Posch, Alexandra, et al.
Publicado: (2020)

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018)

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients
por: Dang, Siwen, et al.
Publicado: (2014)

Assessing Telomere Length Using Surface Enhanced Raman Scattering
por: Zong, Shenfei, et al.
Publicado: (2014)

The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort
por: Wang, Hui, et al.
Publicado: (2019)

Relationship between genetically determined telomere length and glioma risk
por: Saunders, Charlie N, et al.
Publicado: (2021)

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
por: Shi, Jing, et al.
Publicado: (2012)

Silencing of the hTERT gene through RNA interference induces apoptosis via Bax/Bcl-2 in human glioma cells
por: WANG, TUO, et al.
Publicado: (2012)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease
por: Zhang, Weili, et al.
Publicado: (2012)

Polymorphisms in Telomere Length Associated TERC and TERT predispose for Ischemic Stroke in a Chinese Han population
por: Zhang, Shuo, et al.
Publicado: (2017)

Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia
por: Eskandari, Ebrahim, et al.
Publicado: (2018)

Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing
por: Li, Mengdan, et al.
Publicado: (2017)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
por: Chen, Chen, et al.
Publicado: (2014)

The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas
por: Xu, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2kta0k1h4tvoo1f235al6dtact